Kiniksa Pharmaceuticals International, plc (KNSA) vs Lantheus Holdings, Inc. (LNTH)
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
- Lantheus Holdings, Inc. LNTH 99.70 −0.29%
Kiniksa Pharmaceuticals International, plc and Lantheus Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Kiniksa Pharmaceuticals International, plc and Lantheus Holdings, Inc. are of similar size ($6.5B and $6.2B). Lantheus Holdings, Inc. trades at the lower P/E: 23.7× against 73.4×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against 2.35%. Lantheus Holdings, Inc. has the higher net margin (17.7% vs 9.59%) and the lower return on invested capital (14.7% vs 48.9%). Across the 20 metrics below, Lantheus Holdings, Inc. leads on 13 and Kiniksa Pharmaceuticals International, plc on 7.
Valuation
Profitability
| Metric | KNSA | LNTH | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 89.82% | 60.14% | 53.94% |
| Operating margin | 11.92% | 19.43% | 0.00% |
| Net margin | 9.59% | 17.69% | 0.00% |
| Free cash flow margin | 21.74% | 25.24% | 0.00% |
| Return on equity | 14.04% | 22.21% | (0.40%) |
| Return on assets | 10.36% | 12.15% | (3.32%) |
| Return on invested capital | 48.87% | 14.65% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack